跳至主導覽
跳至搜尋
跳過主要內容
國立成功大學 首頁
English
中文
首頁
概要
研究單位
研究成果
專案
學生論文
設備
獎項
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
陳 美瑾
教授
化學工程學系
電子郵件
kokola
mail.ncku.edu
tw
h-index
4794
引文
33
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2005
2023
每年研究成果
概覽
指紋
網路
專案
(19)
研究成果
(53)
類似的個人檔案
(6)
監製作品
(14)
指紋
查看啟用 Mei-Chin Chen 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Engineering & Materials Science
Chitosan
100%
Skin
56%
Stents
51%
Atopic Dermatitis
44%
Acids
42%
Nanoparticles
39%
Drug delivery
39%
Insulin
30%
Block copolymers
30%
Antigens
29%
Heparin
28%
Drug Delivery Systems
27%
Infrared radiation
26%
Targeted drug delivery
26%
Polyphenols
25%
Rats
25%
Biological Availability
21%
Polymers
19%
Hydrogels
19%
Crosslinking
18%
Galactosamine
18%
Micelles
17%
Tissue
16%
Polycaprolactone
16%
Vaccines
15%
Tumors
13%
Photodynamic therapy
13%
Proteins
13%
Nanostructures
13%
Polyethylene glycols
13%
Chemotherapy
13%
Liver
12%
Molecules
12%
Gold nanoparticles
11%
Crystallization kinetics
11%
Antioxidants
11%
Tissue engineering
11%
Homopolymerization
11%
Polyaniline
11%
Alginate
11%
Macromolecules
10%
Polyethylene oxides
10%
Milk
10%
Lanthanum
9%
Self assembly
9%
Nanofibers
9%
Phase behavior
9%
Shape memory effect
9%
Muscle
9%
Lasers
9%
Chemical Compounds
Chitosan
81%
Drug
63%
Sirolimus
50%
Intradermal
36%
Transdermal
36%
Nanoparticle
26%
Geniposidic Acid
26%
Heparin
24%
Block Copolymer
23%
Insulin Derivative
23%
Antigen
21%
Crosslinking
16%
Nanomaterial
14%
Galactosamine
14%
Micelle
14%
Bioavailability
14%
Alcohol
14%
Multilayer
13%
Hydrogel
13%
Macromolecule
12%
Genipin
12%
Adjuvant
11%
Hyaluronate
10%
Collagen
10%
Pluronic
10%
Weight
9%
Tannic Acid
9%
Paclitaxel
9%
Gallate
9%
Ablation
8%
Antiinflammatory
8%
Curcumin
8%
pH Value
8%
Liquid Film
8%
Doxorubicin
7%
Polyphenol
7%
Strength
7%
Alginate
7%
Fibrous Crystal
7%
Heat
7%
Phase Behavior
7%
Biopolymer
7%
Single Monomer Polymer
7%
Nanoporosity
7%
Antioxidant Agent
6%
Immunological Adjuvant
6%
Medicine & Life Sciences
Chitosan
72%
Nanoparticles
42%
Glutamic Acid
40%
poly(lactide)
37%
Pharmaceutical Preparations
25%
Skin
24%
Prostaglandins A
24%
Vaccination
20%
Stents
19%
Sirolimus
19%
Antigens
17%
Vaccines
17%
polycaprolactone
17%
Hydrogels
16%
Drug Delivery Systems
16%
Atopic Dermatitis
15%
Insulin
15%
Paclitaxel
15%
geniposidic acid
14%
O,N-carboxymethylchitosan
14%
polyaniline
13%
Galactosamine
13%
Polymers
13%
Lasers
12%
Micelles
11%
Liver Neoplasms
11%
Streptococcus suis
11%
Poloxamer
11%
Drug-Eluting Stents
11%
Polyvinyl Alcohol
10%
Biological Availability
10%
Zika Virus
10%
Nanofibers
9%
epigallocatechin gallate
9%
Ovalbumin
9%
Reducing Agents
9%
Immunization
9%
Immunologic Factors
9%
Gas Lasers
9%
Alginates
8%
Heparin
8%
Tissue Engineering
8%
Histocompatibility Antigens Class II
8%
